INDV

As of 2026-09-10, INDV scores 45out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. INDV trades at $34.51, 32% below the band floor.

INDV scores 45 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 45. Its strongest factor is value at 71 (strong), where it screens cheap on the model's valuation inputs, followed by quality at 50. The weakest is momentum at 34, where price trend is the soft spot. Among Healthcare stocks it sits in the lower 47% of Healthcare names by composite.

On valuation, INDV is priced near the floor of its own recent range — the cheap end on the model's valuation read. The blended composite before the macro overlay was 47. Same-sector names the model rates nearby include HALO, THC, TGTX.

This is a descriptive factor read on INDV, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where INDV sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for INDV runs $50.97–$74.52. Current price $34.51 sits 32% below the band floor. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.